Annual Shareholders Equity
$4.69 B
+$766.56 M+19.52%
31 December 2023
Summary:
Genmab A/S annual stockholders equity is currently $4.69 billion, with the most recent change of +$766.56 million (+19.52%) on 31 December 2023. During the last 3 years, it has risen by +$1.53 billion (+48.50%). GMAB annual shareholders equity is now at all-time high.GMAB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$4.78 B
+$335.68 M+7.55%
01 September 2024
Summary:
Genmab A/S quarterly stockholders equity is currently $4.78 billion, with the most recent change of +$335.68 million (+7.55%) on 01 September 2024. Over the past year, it has increased by +$374.98 million (+8.51%). GMAB quarterly shareholders equity is now at all-time high.GMAB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GMAB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.5% | +8.5% |
| 3 y3 years | +48.5% | +44.0% |
| 5 y5 years | +282.3% | +160.7% |
GMAB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +48.5% | at high | +44.0% |
| 5 y | 5 years | at high | +282.3% | at high | +160.7% |
| alltime | all time | at high | +6810.3% | at high | +7396.6% |
Genmab A/S Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.78 B(+7.6%) |
| June 2024 | - | $4.45 B(-5.4%) |
| Mar 2024 | - | $4.70 B(+0.2%) |
| Dec 2023 | $4.69 B(+19.5%) | $4.69 B(+6.5%) |
| Sept 2023 | - | $4.41 B(+5.0%) |
| June 2023 | - | $4.20 B(+5.4%) |
| Mar 2023 | - | $3.98 B(+1.4%) |
| Dec 2022 | $3.93 B(+16.2%) | $3.93 B(+11.4%) |
| Sept 2022 | - | $3.52 B(+2.5%) |
| June 2022 | - | $3.44 B(+0.8%) |
| Mar 2022 | - | $3.41 B(+0.9%) |
| Dec 2021 | $3.38 B(+6.9%) | $3.38 B(+1.8%) |
| Sept 2021 | - | $3.32 B(+2.5%) |
| June 2021 | - | $3.24 B(+2.3%) |
| Mar 2021 | - | $3.17 B(+0.2%) |
| Dec 2020 | $3.16 B(+50.1%) | $3.16 B(+8.5%) |
| Sept 2020 | - | $2.91 B(+8.1%) |
| June 2020 | - | $2.70 B(+26.8%) |
| Mar 2020 | - | $2.13 B(+1.0%) |
| Dec 2019 | $2.11 B(+71.6%) | $2.11 B(+14.8%) |
| Sept 2019 | - | $1.83 B(+45.3%) |
| June 2019 | - | $1.26 B(+3.4%) |
| Mar 2019 | - | $1.22 B(-0.5%) |
| Dec 2018 | $1.23 B(+21.5%) | $1.23 B(+11.5%) |
| Sept 2018 | - | $1.10 B(+3.5%) |
| June 2018 | - | $1.06 B(-1.3%) |
| Mar 2018 | - | $1.08 B(+6.6%) |
| Dec 2017 | $1.01 B(+47.3%) | $1.01 B(+16.8%) |
| Sept 2017 | - | $865.29 M(+3.4%) |
| June 2017 | - | $836.74 M(+16.4%) |
| Mar 2017 | - | $719.14 M(+4.8%) |
| Dec 2016 | $686.40 M | $686.40 M(+15.9%) |
| Sept 2016 | - | $592.08 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $560.49 M(+4.7%) |
| Mar 2016 | - | $535.37 M(+4.8%) |
| Dec 2015 | $510.73 M(+53.9%) | $510.73 M(+11.4%) |
| Sept 2015 | - | $458.43 M(+10.1%) |
| June 2015 | - | $416.36 M(+11.0%) |
| Mar 2015 | - | $375.20 M(+13.0%) |
| Dec 2014 | $331.92 M(+171.9%) | $331.92 M(+0.7%) |
| Sept 2014 | - | $329.59 M(+2.9%) |
| June 2014 | - | $320.24 M(-1.4%) |
| Mar 2014 | - | $324.83 M(+166.1%) |
| Dec 2013 | $122.07 M(+79.7%) | $122.07 M(+31.4%) |
| Sept 2013 | - | $92.88 M(+7.1%) |
| June 2013 | - | $86.68 M(+3.3%) |
| Mar 2013 | - | $83.90 M(+23.5%) |
| Dec 2012 | $67.92 M(-19.9%) | $67.92 M(+6.5%) |
| Sept 2012 | - | $63.78 M(-8.1%) |
| June 2012 | - | $69.43 M(-9.2%) |
| Mar 2012 | - | $76.43 M(-9.8%) |
| Dec 2011 | $84.76 M(-56.0%) | $84.76 M(-13.2%) |
| Sept 2011 | - | $97.60 M(-42.9%) |
| June 2011 | - | $170.87 M(-5.8%) |
| Mar 2011 | - | $181.40 M(-5.9%) |
| Dec 2010 | $192.67 M(-22.8%) | $192.67 M(-8.1%) |
| Sept 2010 | - | $209.59 M(+6.0%) |
| June 2010 | - | $197.68 M(-10.2%) |
| Mar 2010 | - | $220.21 M(-11.7%) |
| Dec 2009 | $249.50 M(-39.3%) | $249.50 M |
| Dec 2008 | $410.71 M(-27.2%) | - |
| Dec 2007 | $563.85 M(+98.3%) | - |
| Dec 2006 | $284.33 M(+60.2%) | - |
| Dec 2005 | $177.47 M(-17.5%) | - |
| Dec 2004 | $214.99 M(+17.0%) | - |
| Dec 2003 | $183.75 M(-7.0%) | - |
| Dec 2002 | $197.52 M | - |
FAQ
- What is Genmab A/S annual stockholders equity?
- What is the all time high annual shareholders equity for Genmab A/S?
- What is Genmab A/S annual shareholders equity year-on-year change?
- What is Genmab A/S quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Genmab A/S?
- What is Genmab A/S quarterly shareholders equity year-on-year change?
What is Genmab A/S annual stockholders equity?
The current annual shareholders equity of GMAB is $4.69 B
What is the all time high annual shareholders equity for Genmab A/S?
Genmab A/S all-time high annual stockholders equity is $4.69 B
What is Genmab A/S annual shareholders equity year-on-year change?
Over the past year, GMAB annual stockholders equity has changed by +$766.56 M (+19.52%)
What is Genmab A/S quarterly stockholders equity?
The current quarterly shareholders equity of GMAB is $4.78 B
What is the all time high quarterly shareholders equity for Genmab A/S?
Genmab A/S all-time high quarterly stockholders equity is $4.78 B
What is Genmab A/S quarterly shareholders equity year-on-year change?
Over the past year, GMAB quarterly stockholders equity has changed by +$374.98 M (+8.51%)